Literature DB >> 21742595

Up-regulation of CC chemokine ligand 20 and its receptor CCR6 in the lesional skin of early systemic sclerosis.

Juan Tao1, Lin Li, Zhijian Tan, Yan Li, Jing Yang, Fen Tian, Li Wang, Yali Ren, Guangfen Xu, Xiaoliang He, Guanxin Shen, Yating Tu.   

Abstract

Mononuclear cell (MNC) infiltrate is one of the earliest pathological changes in systemic sclerosis (SSc) skin. However, little is known about the recruitment of these cells into skin lesions. Recently, the role of chemokines has been suggested in the pathogenesis of SSc. Here we studied the expressions and distributions of CC chemokine CCL20 and its receptor CCR6 in early SSc skin lesions and the difference in CCL20 expressions and ability to recruite MNCs of normal dermal fibroblast (NDF) and scleroderma dermal fibroblast (SSDF). We found that the expressions of CCL20 and its receptor CCR6 were obviously up-regulated in SSc in contrast to normal human skin. mRNA levels were significantly expressed in SSc lesional skins vs normal skin tissues. SSDF displayed increased constitutive expressions of CCL20 mRNA and protein. In addition, Th1 cytokines (TNF-α and IL-1β) remarkably increased the expression of CCL20 in both NDF and SSDF in a dose- and time-dependent manner. Supernatants from SSDF showed stronger chemotactic activity to PBMCs than those from NDF. Thus our findings suggest that CCL20 released from cytokine-activated SSDF plays an important role in the induction of SSc by further recruiting more MNCs to the skin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742595     DOI: 10.1684/ejd.2011.1469

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  7 in total

1.  Induction of a type I interferon signature in normal human monocytes by gadolinium-based contrast agents: comparison of linear and macrocyclic agents.

Authors:  P J Wermuth; S A Jimenez
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

2.  Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.

Authors:  Allison L Mathes; Romy B Christmann; Giuseppina Stifano; Alsya J Affandi; Timothy R D J Radstake; G Alessandra Farina; Cristina Padilla; Sarah McLaughlin; Robert Lafyatis
Journal:  Ann Rheum Dis       Date:  2013-07-19       Impact factor: 19.103

Review 3.  Current perspectives on the role of CD8+ T cells in systemic sclerosis.

Authors:  Patrizia Fuschiotti
Journal:  Immunol Lett       Date:  2017-10-05       Impact factor: 3.685

4.  Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mice.

Authors:  Remy Robert; Caroline Ang; Guizhi Sun; Laurent Juglair; Ee X Lim; Linda J Mason; Natalie L Payne; Claude Ca Bernard; Charles R Mackay
Journal:  JCI Insight       Date:  2017-08-03

5.  A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6.

Authors:  Remy Robert; Laurent Juglair; Ee X Lim; Caroline Ang; Carl J H Wang; Gregor Ebert; Olan Dolezal; Charles R Mackay
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

6.  Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis.

Authors:  Tetsuya Ikawa; Takuya Miyagawa; Yuki Fukui; Satoshi Toyama; Jun Omatsu; Kentaro Awaji; Yuta Norimatsu; Yusuke Watanabe; Ayumi Yoshizaki; Shinichi Sato; Yoshihide Asano
Journal:  Arthritis Res Ther       Date:  2021-11-13       Impact factor: 5.156

7.  Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin.

Authors:  Joanna Nikitorowicz-Buniak; Christopher P Denton; David Abraham; Richard Stratton
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.